Sunday, October 18, 2026 from 4:00 p.m. to 5:30 p.m. MDT at Salt Palace Convention Center - Ballroom J
Available for 1.50 hours of CPE creditActivity Type: A Knowledge-Based ActivityThis session will enhance pharmacists’ knowledge of immune checkpoint inhibitors (ICIs), including their oncologic use and key considerations during the pre- and post-transplantation phases. As the role of ICIs in various cancers continues to evolve, it is essential for pharmacists to understand the impact of these agents on transplant care to provide informed recommendations to the multidisciplinary team. As medication experts, pharmacists play an important role in assessing the risks and benefits of ICIs in the phases of the transplant process. Learners will have the opportunity to engage with presenters through real-world examples along with audience response and multiple-choice questions to illustrate the challenges and successes in this emerging area of pharmacotherapy.
Learning Objectives1. Examine immunologic mechanisms and adverse effects associated with immune checkpoint inhibitor use.
2. Summarize the role of immune checkpoint inhibitor therapy in the pre- and-post transplant setting for hepatocellular carcinoma and skin cancer, respectively.
3. Identify the risks associated with the use of immune checkpoint inhibitors for cancer therapy in the pre- and post-transplant phases.
4. Outline an assessment and management plan for the consideration of immune checkpoint Inhibitor use in the pre- and post-transplant setting.
 | | Moderator: | Marissa M. Brokhof, Pharm.D., BCPS, BCTXP |
|
An Overview of Immune Checkpoint Inhibitors from the Drug Information Experts 4:00 p.m. to 4:25 p.m. | | Speaker: | Kristen D. Belfield, Pharm.D., BCTXP |
|
|
Revolutionizing Cancer Treatment: The Use of Immune Checkpoint Inhibitors 4:25 p.m. to 4:50 p.m. | | Speaker: | Abbie D. Leino, Pharm.D., Ph.D., BCPS |
|
|
The Role of the Pharmacist: Managing Immune Checkpoint Inhibitor Use Pre- and Post-Transplant 4:50 p.m. to 5:15 p.m. | | Speaker: | Mary Leick, Pharm.D., BCPS, BCTXP |
|
|
Question & Answer Panel5:15 p.m. to 5:30 p.m. |